TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Biosimilar Monoclonal Antibodies Market
Biosimilar Monoclonal Antibodies Market 2024-2030 by Player, Region, Type, Application and Sales Channel

Biosimilar Monoclonal Antibodies Market 2024-2030 by Player, Region, Type, Application and Sales Channel

  • Category:Life Sciences
  • Published on : 20 August 2024
  • Pages :88
  • Formats:
  • Report Code:SMR-7987046
OfferClick for best price

Best Price: $2000

Biosimilar Monoclonal Antibodies Market Size, Share 2024


The global Biosimilar Monoclonal Antibodies market size is estimated to be $xx million in 2023, and it will reach $xx million by 2032, growing at a CAGR of xx% during the forecast period from 2024 to 2032.

This report studies the Biosimilar Monoclonal Antibodies market, covering market size for segment by type (Infliximab, Rituximab, etc.), by application (Oncology, Autoimmune Disease, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), Dr Reddy?s, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Biosimilar Monoclonal Antibodies from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biosimilar Monoclonal Antibodies market.

Leading Players of Biosimilar Monoclonal Antibodies including:

Celltrion

Pfizer (Hospira)

3SBIO

Novartis (Sandoz)

Dr Reddy?s

Celgen Biopharma

Cadila Healthcare

Hisun Pharma

Torrent Pharmaceuticals

Biocon

Market split by Type:

Infliximab

Rituximab

Trastuzumab

Adalimumab

Others

Market split by Application:

Oncology

Autoimmune Disease

Others

Market split by Sales Channel:

Direct Channel

Distribution Channel

Market split by Region/Country:

North America (United States and Canada)

Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)

South America (Brazil, Mexico, and Argentina, etc.)

Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Report Attributes Report Details
Report Title Biosimilar Monoclonal Antibodies Market 2024-2030 by Player, Region, Type, Application and Sales Channel
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 88 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents

Chapter 1 Biosimilar Monoclonal Antibodies Market Overview
1.1 Biosimilar Monoclonal Antibodies Definition
1.2 Global Biosimilar Monoclonal Antibodies Market Size Status and Outlook (2018-2032)
1.3 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Region (2018-2032)
1.4 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Type (2018-2032)
1.5 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Application (2018-2032)
1.6 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Sales Channel (2018-2032)
1.7 Biosimilar Monoclonal Antibodies Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Biosimilar Monoclonal Antibodies Market
Chapter 2 Biosimilar Monoclonal Antibodies Market Competition by Player
2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Player (2021-2023)
2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2021-2023)
2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Monoclonal Antibodies Market Segment by Type
3.1 Global Biosimilar Monoclonal Antibodies Market by Type
3.1.1 Infliximab
3.1.2 Rituximab
3.1.3 Trastuzumab
3.1.4 Adalimumab
3.1.5 Others
3.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2018-2023)
3.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2018-2023)
3.4 Global Biosimilar Monoclonal Antibodies Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Biosimilar Monoclonal Antibodies Market Segment by Application
4.1 Global Biosimilar Monoclonal Antibodies Market by Application
4.1.1 Oncology
4.1.2 Autoimmune Disease
4.1.3 Others
4.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Biosimilar Monoclonal Antibodies Market Segment by Sales Channel
5.1 Global Biosimilar Monoclonal Antibodies Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Monoclonal Antibodies Market Segment by Region & Country
6.1 Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2018-2032)
6.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2018-2023)
6.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Monoclonal Antibodies Market Share by Type
6.4.3 North America Biosimilar Monoclonal Antibodies Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Monoclonal Antibodies Market Share by Type
6.5.3 Europe Biosimilar Monoclonal Antibodies Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type
6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Monoclonal Antibodies Market Share by Type
6.7.3 South America Biosimilar Monoclonal Antibodies Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type
6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies Players
7.1 Celltrion
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Pfizer (Hospira)
7.3 3SBIO
7.4 Novartis (Sandoz)
7.5 Dr Reddy?s
7.6 Celgen Biopharma
7.7 Cadila Healthcare
7.8 Hisun Pharma
7.9 Torrent Pharmaceuticals
7.10 Biocon
Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies
8.1 Industrial Chain of Biosimilar Monoclonal Antibodies
8.2 Upstream of Biosimilar Monoclonal Antibodies
8.3 Downstream of Biosimilar Monoclonal Antibodies
Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (2024-2032)
9.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

LIST OF TABLES & FIGURES

List of Tables and Figures

Figure Biosimilar Monoclonal Antibodies Example
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Status and Outlook (2018-2032)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Region (2018-2032)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Type (2018-2032)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Application (2018-2032)
Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Sales Channel (2018-2032)
Table Global Biosimilar Monoclonal Antibodies Sales by Player (2021-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Player (2021-2023)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Player in 2023
Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Player (2021-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player (2021-2023)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player in 2023
Table Global Biosimilar Monoclonal Antibodies Average Price by Player (2021-2023)
Figure Global Biosimilar Monoclonal Antibodies Average Price by Player in 2023
Figure Global Biosimilar Monoclonal Antibodies Players Competition Situation ? Top 5 Players? Revenue Market Share in 2021
Figure Global Biosimilar Monoclonal Antibodies Players Competition Trends ? Top 5 Players? Revenue Market Share in 2023
Figure Example of Infliximab
Figure Global Infliximab Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Rituximab
Figure Global Rituximab Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Trastuzumab
Figure Global Trastuzumab Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Adalimumab
Figure Global Adalimumab Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales by Type (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2023
Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Type (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2023
Table Global Biosimilar Monoclonal Antibodies Average Price by Type (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Average Price by Type in 2023
Table Leading Players of Biosimilar Monoclonal Antibodies by Type in 2023
Figure Example of Oncology
Figure Global Biosimilar Monoclonal Antibodies for Oncology Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Autoimmune Disease
Figure Global Biosimilar Monoclonal Antibodies for Autoimmune Disease Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Others
Figure Global Biosimilar Monoclonal Antibodies for Others Revenue (Million $) and Growth Rate (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales by Application (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2023
Table Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2023
Figure Example of Direct Channel
Figure Global Biosimilar Monoclonal Antibodies for Direct Channel Revenue (Million $) and Growth Rate (2018-2023)
Figure Example of Distribution Channel
Figure Global Biosimilar Monoclonal Antibodies for Distribution Channel Revenue (Million $) and Growth Rate (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue by Sales Channel (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Sales Channel (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Sales Channel in 2023
Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2023
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2018-2032)
Table Global Biosimilar Monoclonal Antibodies Sales by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2023
Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Region (2018-2023)
Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2018-2023)
Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2023
Table North America Biosimilar Monoclonal Antibodies Sales by Country (2018-2023)
Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2018-2023)
Table North America Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023)
Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2018-2023)
Figure North America Biosimilar Monoclonal Antibodies Market Share by Type in 2023
Figure North America Biosimilar Monoclonal Antibodies Market Share by Application in 2023
Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure United States Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Canada Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Table Europe Biosimilar Monoclonal Antibodies Sales by Country (2018-2023)
Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2018-2023)
Table Europe Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023)
Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2018-2023)
Figure Europe Biosimilar Monoclonal Antibodies Market Share by Type in 2023
Figure Europe Biosimilar Monoclonal Antibodies Market Share by Application in 2023
Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Germany Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure UK Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure France Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Italy Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Spain Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Russia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Country (2018-2023)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Country (2018-2023)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2018-2023)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type in 2023
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application in 2023
Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure China Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Korea Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure India Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Australia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Table South America Biosimilar Monoclonal Antibodies Sales by Country (2018-2023)
Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2018-2023)
Table South America Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023)
Figure South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2018-2023)
Figure South America Biosimilar Monoclonal Antibodies Market Share by Type in 2023
Figure South America Biosimilar Monoclonal Antibodies Market Share by Application in 2023
Figure Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Brazil Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Argentina Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Colombia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Country (2018-2023)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2018-2023)
Table Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2018-2023)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2018-2023)
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type in 2023
Figure Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application in 2023
Figure Turkey Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Turkey Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure UAE Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Figure South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Figure South Africa Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2018-2023)
Table Company Snapshot of Celltrion
Table Biosimilar Monoclonal Antibodies Introduction of Celltrion
Table Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share of Celltrion (2021-2023)
Table Industrial Chain of Biosimilar Monoclonal Antibodies
Table Leading Consumers of Biosimilar Monoclonal Antibodies
Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2024-2032)
Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2024-2032)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2024-2032)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2024-2032)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2024-2032)
Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2024-2032)

Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User License
USD Enterprise License

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount